127 related articles for article (PubMed ID: 3828253)
1. Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal women.
Jensen J; Riis BJ; Strøm V; Christiansen C
Br J Obstet Gynaecol; 1987 Feb; 94(2):130-5. PubMed ID: 3828253
[TBL] [Abstract][Full Text] [Related]
2. Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
Jensen J; Riis BJ; Strøm V; Christiansen C
Maturitas; 1989 Jun; 11(2):117-28. PubMed ID: 2547137
[TBL] [Abstract][Full Text] [Related]
3. Cyproterone acetate, an alternative progestogen in postmenopausal hormone replacement therapy? Effects on serum lipids and lipoproteins.
Jensen J; Riis BJ; Christiansen C
Br J Obstet Gynaecol; 1987 Feb; 94(2):136-41. PubMed ID: 3030392
[TBL] [Abstract][Full Text] [Related]
4. Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women.
Jensen J; Christiansen C
Maturitas; 1987 Nov; 9(3):259-66. PubMed ID: 3323852
[TBL] [Abstract][Full Text] [Related]
5. Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.
Jensen J; Nilas L; Christiansen C
Br J Obstet Gynaecol; 1986 Jun; 93(6):613-8. PubMed ID: 3730329
[TBL] [Abstract][Full Text] [Related]
6. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
Christiansen C; Riis BJ
Br J Obstet Gynaecol; 1990 Dec; 97(12):1087-92. PubMed ID: 2126198
[TBL] [Abstract][Full Text] [Related]
7. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein and apolipoprotein levels in postmenopausal women on continuous oestrogen/progestogen therapy.
Farish E; Fletcher CD; Dagen MM; Hart DM; Al-Azzawi F; Parkin DE; Howie CA
Br J Obstet Gynaecol; 1989 Mar; 96(3):358-64. PubMed ID: 2713295
[TBL] [Abstract][Full Text] [Related]
9. Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate.
Owens D; Collins PB; Johnson A; Tomkin GH
Diabet Med; 2000 Apr; 17(4):308-15. PubMed ID: 10821298
[TBL] [Abstract][Full Text] [Related]
10. Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy.
Jensen J; Christiansen C
Am J Obstet Gynecol; 1988 Oct; 159(4):820-5. PubMed ID: 2972209
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen.
Mattsson LA; Samsioe G
Acta Obstet Gynecol Scand Suppl; 1985; 130():53-8. PubMed ID: 3859976
[TBL] [Abstract][Full Text] [Related]
12. A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism.
Mattsson LA; Cullberg G; Samsioe G
Acta Obstet Gynecol Scand; 1984; 63(8):673-7. PubMed ID: 6524301
[TBL] [Abstract][Full Text] [Related]
13. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
Ylikorkala O; Lim P; Caubel P
Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
[TBL] [Abstract][Full Text] [Related]
14. The effect of menopausal status and sequential mestranol and norethisterone on serum cholesterol, triglyceride and electrophoretic lipoprotein patterns.
Paterson ME; Sturdee DW; Moore B; Whitehead TP
Br J Obstet Gynaecol; 1979 Oct; 86(10):810-5. PubMed ID: 508663
[TBL] [Abstract][Full Text] [Related]
15. Effect on lipoproteins of Trisequens, a combined hormone preparation.
Fletcher CD; Farish E; Hart DM; Leggate J; Clark DM; Kitchener H; Sharpe GL
Maturitas; 1984 Nov; 6(3):279-83. PubMed ID: 6595494
[TBL] [Abstract][Full Text] [Related]
16. Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial.
Munk-Jensen N; Ulrich LG; Obel EB; Nielsen SP; Edwards D; Meinertz H
Am J Obstet Gynecol; 1994 Jul; 171(1):132-8. PubMed ID: 8030688
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of continuous estradiol-progestin therapy in postmenopausal women.
Sporrong T; Hellgren M; Samsioe G; Mattsson LA
Obstet Gynecol; 1989 May; 73(5 Pt 1):754-8. PubMed ID: 2704503
[TBL] [Abstract][Full Text] [Related]
18. Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment.
Christiansen C; Christensen MS; Grande P; Transbøl I
Maturitas; 1984 Mar; 5(3):193-9. PubMed ID: 6727693
[TBL] [Abstract][Full Text] [Related]
19. Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I.
Miller VT; Muesing RA; LaRosa JC; Stoy DB; Phillips EA; Stillman RJ
Obstet Gynecol; 1991 Feb; 77(2):235-40. PubMed ID: 1846437
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone replacement therapy and plasma lipoproteins.
Taskinen MR
J Intern Med; 1995 Nov; 238(5):385-7. PubMed ID: 7595177
[No Abstract] [Full Text] [Related]
[Next] [New Search]
